Breaking News

BREAKING: HHS’s Top Lawyer Says Pharma’s 340B Contract Pharmacy Actions Are at Odds with the Law

“Certain manufacturers’ newfound and unilateral refusal to sell [340B] drugs through contract pharmacies is at odds with the structure and intended operation of the [340B] statute,” HHS General Counsel Robert Charrow said in an advisory opinion late today. | Source:
Read More »

Trump Pardons Disgraced 340B Critic

Read More »

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

Drug manufacturer vendor Kalderos says it expects several companies to begin using its 340B Pay platform during the next three months.

 

Kalderos Expects its 340B Rebate Model

Read More »

Providers Are Pleased, PhRMA Isn’t, With Becerra and State AGs’ 340B Letter to Azar

Editor’s note—A cascade of breaking 340B news developments over the past seven days—Amgen’s orphan drug action, HRSA’s dispute resolution final rule, the hospital lawsuit against HHS, the state attorneys general letter to HHS and the new GAO report—forced us to

Read More »